Shield Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '26 Mar 5, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	97	21	52	18	96	75
Market Cap Growth	225.00%	-59.70%	186.53%	-80.96%	28.62%	-64.39%
Enterprise Value	108	31	46	16	73	68
Last Close Price	0.09	0.03	0.07	0.07	0.43	0.60
PS Ratio	3.19	0.82	5.10	4.01	63.24	7.19
PB Ratio	-8.91	-20.07	4.44	3.37	2.36	2.47
P/TBV Ratio	-	-	4.82	4.15	4.11	6.53
P/FCF Ratio	26.19	-	-	-	-	-
P/OCF Ratio	26.19	-	-	-	-	-
EV/Sales Ratio	3.58	1.19	4.50	3.48	48.36	6.56
EV/EBITDA Ratio	-	-	-	-	-	2840.59
EV/FCF Ratio	29.41	-	-	-	-	-
Debt / Equity Ratio	-1.82	-20.02	1.35	1.04	0.00	0.00
Debt / EBITDA Ratio	-	-	-	-	-	1.17
Debt / FCF Ratio	5.35	-	-	-	-	-
Net Debt / Equity Ratio	-1.09	-15.07	0.42	0.52	-0.29	-0.10
Net Debt / EBITDA Ratio	-1.13	-0.89	-0.20	-0.11	0.64	-121.33
Net Debt / FCF Ratio	3.21	-2.92	-0.17	-0.15	0.64	2.08
Asset Turnover	0.76	0.61	0.35	0.14	0.04	0.30
Inventory Turnover	3.98	3.89	3.65	1.63	0.65	1.16
Quick Ratio	0.69	0.90	1.83	0.62	3.73	1.60
Current Ratio	0.83	1.16	2.28	0.95	4.64	2.32
Return on Equity (ROE)	-	-396.36%	-308.60%	-179.19%	-55.46%	-8.43%
Return on Assets (ROA)	-16.77%	-26.90%	-51.93%	-49.37%	-32.97%	-3.91%
Return on Capital Employed (ROCE)	-120.80%	-92.00%	-89.40%	-229.50%	-49.90%	-7.10%
Earnings Yield	-16.05%	-102.83%	-49.88%	-225.97%	-20.48%	-3.52%
FCF Yield	3.82%	-25.74%	-55.98%	-102.82%	-19.40%	-1.87%
Buyback Yield / Dilution	-19.74%	-8.33%	-209.85%	-14.08%	-74.36%	-0.21%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.